Cargando…

PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity

Diabetes is a multi-organ disease and diabetic cardiomyopathy can result in heart failure, which is a leading cause of morbidity and mortality in diabetic patients. In the liver, insulin resistance contributes to hyperglycaemia and hyperlipidaemia, which further worsens the metabolic profile. Defect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Völkers, Mirko, Doroudgar, Shirin, Nguyen, Nathalie, Konstandin, Mathias H, Quijada, Pearl, Din, Shabana, Ornelas, Luis, Thuerauf, Donna J, Gude, Natalie, Friedrich, Kilian, Herzig, Stephan, Glembotski, Christopher C, Sussman, Mark A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936489/ https://www.ncbi.nlm.nih.gov/pubmed/24408966 http://dx.doi.org/10.1002/emmm.201303183

Ejemplares similares

mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)

PRAS40 signaling in tumor
por: Lv, Dan, et al.
Publicado: (2017)

PRAS40 hyperexpression promotes hepatocarcinogenesis
por: Qi, Zhaolai, et al.
Publicado: (2020)

PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells
por: Zhang, Kevin Sun, et al.
Publicado: (2019)

mTORC1 inhibition impairs activation of the unfolded protein response and induces cell death during ER stress in cardiomyocytes
por: Hofmann, Christoph, et al.
Publicado: (2023)

Proteomic analysis of the cardiac myocyte secretome reveals extracellular protective functions for the ER stress response
por: Blackwood, Erik A., et al.
Publicado: (2020)

PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Prognostic role of phospho-PRAS40 (Thr246) expression in gastric cancer
por: Lu, Yi-Zhuo, et al.
Publicado: (2013)

Structural Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
por: Yang, Haijuan, et al.
Publicado: (2017)

Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells
por: Chen, Kun, et al.
Publicado: (2019)

TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner
por: Shen, Wenzhi, et al.
Publicado: (2022)

PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis
por: Thedieck, Kathrin, et al.
Publicado: (2007)

PRAS40 promotes NF-κB transcriptional activity through association with p65
por: Zhu, G, et al.
Publicado: (2017)

Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
por: Qi, Zhaolai, et al.
Publicado: (2020)

The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma
por: Chen, Gang, et al.
Publicado: (2021)

A Role for the p38 Mitogen-activated Protein Kinase Pathway in Myocardial Cell Growth, Sarcomeric Organization, and Cardiac-specific Gene Expression
por: Zechner, Dietmar, et al.
Publicado: (1997)

Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats
por: Cao, Yunshan, et al.
Publicado: (2017)

High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma
por: Zhou, Jintuo, et al.
Publicado: (2020)

MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40
por: Zhang, Han, et al.
Publicado: (2019)

A Multi-Network Comparative Analysis of Transcriptome and Translatome Identifies Novel Hub Genes in Cardiac Remodeling
por: Boileau, Etienne, et al.
Publicado: (2020)

Corrigendum: A Multi-Network Comparative Analysis of Transcriptome and Translatome Identifies Novel Hub Genes in Cardiac Remodeling
por: Boileau, Etienne, et al.
Publicado: (2021)

Phospho-PRAS40(Thr246) predicts trastuzumab response in patients with HER2-positive metastatic breast cancer
por: YUAN, KAI, et al.
Publicado: (2015)

Aescin Protects Neuron from Ischemia-Reperfusion Injury via Regulating the PRAS40/mTOR Signaling Pathway
por: Gao, Xinjie, et al.
Publicado: (2020)

TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
por: Xie, Yingbin, et al.
Publicado: (2020)

Effect of PI3K/Akt Signaling Pathway on PRAS40Thr246 Phosphorylation in Gastric Cancer Cells
por: LU, Yizhuo, et al.
Publicado: (2019)

PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40
por: Zhang, Tianhua, et al.
Publicado: (2022)

p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway
por: Zhao, Jianlan, et al.
Publicado: (2021)

Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
por: Basu, Aninda, et al.
Publicado: (2011)

PTEN inhibitor VO-OHpic suppresses TSC2(-)(/)(-) MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathway
por: Wang, Wenda, et al.
Publicado: (2020)

Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14
por: Sanjurjo, Lucía, et al.
Publicado: (2023)

Muscle‐specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling
por: Górska, Agnieszka A, et al.
Publicado: (2021)

Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality
por: Shipitsin, Michail, et al.
Publicado: (2014)

AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
por: Mi, Wenting, et al.
Publicado: (2015)

Phosphorylation of PRAS40 contributes to the activation of the PI3K/AKT/mTOR signaling pathway and the inhibition of autophagy following status epilepticus in rats
por: Lin, Junyi, et al.
Publicado: (2020)

Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
por: Oudaert, Inge, et al.
Publicado: (2022)

Interaction Between CD34(+) Fibrocytes and Airway Smooth Muscle Promotes IL-8 Production and Akt/PRAS40/mTOR Signaling in Asthma
por: Lin, Ting-Yu, et al.
Publicado: (2022)

Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
por: Blackwood, Erik A., et al.
Publicado: (2019)

P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death
por: Bian, Shu, et al.
Publicado: (2013)

Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway
por: Havel, Jonathan J., et al.
Publicado: (2014)

PRAS: Predicting functional targets of RNA binding proteins based on CLIP-seq peaks
por: Lin, Jianan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hpui52q0tfpmks1mf6o5dbbmi1